All Photos(1)



Cibacron Blue 3GA Agarose

Type 300, saline suspension

MDL number:
PubChem Substance ID:


Type 300


saline suspension

extent of labeling

0.2-0.5 μmol per mL


4% beaded agarose


1,000-4,000 units/mL binding capacity (lactic dehydrogenase)
1-5 mg/mL binding capacity (bovine serum albumin)

storage temp.


SMILES string




InChI key


Looking for similar products? Visit Product Comparison Guide

Physical form

Suspension in 0.5 M NaCl containing preservative.

Certificate of Analysis

Enter Lot Number to search for Certificate of Analysis (COA).

Certificate of Origin

Enter Lot Number to search for Certificate of Origin (COO).

Andreas Brunschweiger et al.
Journal of medicinal chemistry, 51(15), 4518-4528 (2008-07-18)
Ecto-nucleoside triphosphate diphosphohydrolases (E-NTPDases, subtypes 1, 2, 3, 8 of NTPDases) dephosphorylate nucleoside tri- and diphosphates to the corresponding di- and monophosphates. In the present study we synthesized adenine and uracil nucleotide mimetics, in which the phosphate residues were replaced
Stefanie Weyler et al.
Bioorganic & medicinal chemistry letters, 18(1), 223-227 (2007-11-17)
A library of anilinoanthraquinone derivatives was synthesized by parallel Ullmann coupling reaction of bromaminic acid with aniline derivatives in solution using a compact parallel synthesizer. The products were purified by HPLC and evaluated as antagonists at mouse and human P2Y2
Christa E Müller et al.
Bioorganic & medicinal chemistry letters, 16(23), 5943-5947 (2006-09-26)
Polyoxotungstates were identified as potent inhibitors of NTPDases1, 2, and 3. The most potent compound was K(6)H(2)[TiW(11)CoO(40)], exhibiting K(i) values of 0.140 microM (NTPDase1), 0.910 microM (NTPDase2), and 0.563 microM (NTPDase3). One of the compounds, (NH(4))(18)[NaSb(9)W(21)O(86)], was selective for NTPDases2
Younis Baqi et al.
Journal of medicinal chemistry, 53(5), 2076-2086 (2010-02-12)
ecto-5'-Nucleotidase (eN, CD73) plays a major role in controlling extracellular adenosine levels. eN inhibitors have potential as novel drugs, for example, for the treatment of cancer. In the present study, we synthesized and investigated a series of 55 anthraquinone derivatives
Petra Hillmann et al.
Journal of medicinal chemistry, 52(9), 2762-2775 (2009-05-08)
The P2Y(2) receptor, which is activated by UTP, ATP, and dinucleotides, was studied as a prototypical nucleotide-activated GPCR. A combination of receptor mutagenesis, determination of its effects on potency and efficacy of agonists and antagonists, homology modeling, and chemical experiments

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service